Polymyxin-resistant clinical isolates of Escherichia coli

Antimicrob Agents Chemother. 2011 Jan;55(1):388-9. doi: 10.1128/AAC.01088-10. Epub 2010 Nov 1.

Abstract

A surveillance study to identify patients from the community with Escherichia coli resistant to broad-spectrum cephalosporins discovered two isolates that were also resistant to polymyxin B and colistin. One isolate from a patient in the community and a second from a patient who received multiple courses of polymyxin B also possessed a CTX-M-15 enzyme. Resistance to cationic peptides in E. coli is unusual, and testing for susceptibility to these agents should be performed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Colistin / pharmacology
  • Escherichia coli / drug effects*
  • Escherichia coli / pathogenicity
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Polymyxin B / pharmacology
  • Polymyxins / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Polymyxins
  • Polymyxin B
  • Colistin